Insulin-like Growth Factor Binding Protein-3 expression in the human corneal epithelium.
Insulin-like Growth Factor Binding Protein-3 (IGFBP3) is a high-affinity binding protein shown to regulate cell growth, differentiation, and apoptosis in a variety of cellular systems. The primary aim of this study was to characterize IGFBP3 expression in the human corneal epithelium and in a corneal epithelial cell line and to establish a potential role for IGFBP3-mediated apoptotic signaling in corneal epithelial cells. Using a telomerase-immortalized human corneal epithelial (hTCEpi) cell line cultured in serum-free media and fresh human eye bank donor tissue, expression and localization of IGFBP3 were established in situ and in vitro by indirect immunofluorescence and western blotting. Real-time PCR was used to measure IGFBP3 mRNA levels following Trichostatin A (TSA) treatment and as a function of confluence. IGFBP3 protein levels were assessed in resting human tears and in conditioned media by western blotting as was the ability of recombinant human IGFBP3 protein to associate with the cell surface. Apoptotic signaling was assessed in vitro using TSA and recombinant human (rh)IGFBP3. Apoptosis was measured by Viability/Cytotoxicity, Annexin V, and TUNEL assays. IGFBP3 was localized to the plasma membrane of human corneal epithelial cells in situ and was upregulated in surface cells in the central cornea. IGFBP3 was secreted in conditioned media of growing cells, with a robust upregulation following confluence (P=0.014) and differentiation. IGFBP3 was undetectable in human tears. Addition of TSA to the culture media resulted in an upregulation of IGFBP3 mRNA (P<0.001) and protein. In addition, TSA treatment led to a significant increase in Annexin V positive cells at 18 and 24h (P<0.001) and TUNEL positive cells at 24 and 48 h (P<0.001). The addition of rhIGFBP3 to the cell culture media appeared to induce occasional membrane blebbing, but cells failed to become positive with Annexin V or TUNEL. Taken together, these results demonstrate that cell membrane-associated IGFBP3 is produced by corneal epithelial cells and associates with the plasma membrane of superficial cells in situ and in cultured cells, but not present in human tears. The differential localization and effect(s) on apoptosis suggest that the effects of IGFBP3 are likely tissue compartment and receptor specific and may be regulated by glycosylation.
Robertson
Danielle M
DM
Department of Ophthalmology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9057, USA. danielle.robertson@utsouthwestern.edu
Ho
Su-Inn
SI
Hansen
Baranda S
BS
Petroll
W Matthew
WM
Cavanagh
H Dwight
HD
D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D002454:Cell Differentiation / Q000502:physiology; D002462:Cell Membrane / Q000378:metabolism; D049109:Cell Proliferation; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology; D019573:Epithelium, Corneal / Q000166:cytology / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics; D011994:Recombinant Proteins / Q000494:pharmacology; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods
D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; D018972:Insulin-Like Growth Factor Binding Protein 3; D012333:RNA, Messenger; D011994:Recombinant Proteins; C012589:trichostatin A
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):864-72
16505018
Mol Biol Cell. 2003 Nov;14(11):4569-80
12937269
Endocrinology. 2002 Jul;143(7):2693-9
12072403
J Cell Physiol. 1999 May;179(2):201-7
10199559
Proc Natl Acad Sci U S A. 1989 Sep;86(18):6898-902
2476804
Apoptosis. 2001 Jun;6(3):199-205
11388669
CLAO J. 2001 Oct;27(4):221-4
11725986
Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3810-5
12939296
Exp Eye Res. 2001 Aug;73(2):247-55
11446775
Invest Ophthalmol Vis Sci. 2006 Feb;47(2):591-8
16431955
Cell Growth Differ. 2002 Apr;13(4):163-71
11971816
J Endocrinol. 1999 Mar;160(3):379-87
10076184
Endocr Rev. 2002 Dec;23(6):824-54
12466191
J Biol Chem. 1999 Mar 12;274(11):6935-45
10066747
J Biol Chem. 1999 Mar 5;274(10):6711-7
10037769
Invest Ophthalmol Vis Sci. 2002 Apr;43(4):963-7
11923235
Cornea. 2002 Jan;21(1):85-90
11805514
Invest Ophthalmol Vis Sci. 1996 May;37(6):1017-25
8631617
J Biol Chem. 2006 Aug 25;281(34):24588-601
16793770
CLAO J. 2002 Jan;28(1):48-54
11838990
Ocul Surf. 2005 Oct;3(4):194-202
17131028
Glycobiology. 1995 Feb;5(1):3-10
7539645